Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold reacting to global flash points

Gold’s safe haven status was tested this week, as Iran countered the assassination of its top military commander with missile strikes against two Iraqi bases housing US troops. On Tuesday night Tehran fired over a dozen missiles at the Al-Asad airbase and E...
Richard (Rick) Mills | January 10, 2020 |

The Repatriators

The Europeans want their gold back. Amid global trade uncertainty, a pall hanging over the European Union due to continued economic weakness , the exit of Great Britain still a real possibility, and dark, nationalist undercurrents swirling, several of the 28-strong EU mem...
Richard (Rick) Mills | December 16, 2019 |

With Contact Tracing Key to Reopening the Economy, New Cloud Platform Attracting High-Profile Users

As contact tracing moves to center stage as a key to reopening the economy, HealthSpace releases a scalable cloud-based system that is rapidly being adopted, including by the state of Hawaii. HealthSpace Data Systems Ltd. (HS:CSE; HSDLF:OTCMKTS) , a Software...
Streetwise Reports | April 29, 2020 |

Acting on the Prospects for the Oil Rally’s Continuation

In our previous analysis, we wrote about crude oil’s strength. We emphasized how it was able to break above its declining resistance line and open the day with a price gap, despite numerous previous signals that had been pointing to the downside. We wrote tha...
Nadia Simmons | May 8, 2020 |

Buzz on the Bullboards: Who is the Latest Hot Play?

(Image via BlackBerry Limited.) From short-term healthcare plays, long-term technology bets, to uncertain cannabis swings … small-cap investors have had their hands full keeping up with the markets over the past few months. We’ve noted that each...
Stockhouse Editorial | May 4, 2022 |

Clinical Program Started for Agitation with Schizophrenia, Bipolar Disorder

The design of and an opinion on the included studies are provided in an H.C. Wainwright & Co. report. In a Dec. 30 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that BioXcel Therapeutics Inc. (BTAI:NASDAQ) launched its pivotal trial program for...
Streetwise Reports | January 6, 2020 |

Biopharma's New License Agreement with Gilead 'Brings Strong Validation and Economics'

The specifics and benefits of the deal are discussed in an H.C. Wainwright & Co. report. In a July 22 research note, H.C. Wainwright & Co. analyst Ed Arce reported that DURECT Corp. (DRRX:NASDAQ) entered an agreement concerning its SABER technology and SAB...
Streetwise Reports | July 24, 2019 |

The Psychedelic Opportunity You Need to Know About

When Stockhouse Editorial last caught up with Toronto-based CYBIN Inc. ( N.CYBN , OTC: CYBN , Forum ) back in September 2020 , the psychedelic life sciences company was just going public…and to much fanfare. Cybin is a life sciences company that views psychedelic subst...
Dave Jackson | October 19, 2021 |

Biotech to Launch Preclinical Studies of Antibody in Eight Cancer Types

This company's new trials, preferred dosing and upcoming biologics license application submission are discussed in an H.C. Wainwright & Co. report. In a Feb. 20 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that CytoDyn Inc. (CYDY:OTCQB) plans to...
Streetwise Reports | March 1, 2019 |

After Financing Close, Biotech's Subsidiary to Operate Independently

An H.C. Wainwright & Co. report explained the purpose of the funding and how any resulting developments would positively impact the former parent company. In a Feb. 22 research report, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Inovio Pharmaceuticals In...
Streetwise Reports | March 6, 2019 |
1 2 3 4 5 6 7 8 9 10 ...